Contents & References of Investigating the effect of Familact probiotic supplement on blood sugar indices, lipid profile and insulin level in patients with type 2 diabetes.
List:
Chapter 1 - Introduction and statement of the problem. 1
1-1 Introduction 2
1-2 statement of the problem and importance of the research. 2
1-3 objectives and assumptions. 8
1-3-1 main objectives. 8
1-3-3 research questions. 9
1-3-4 research assumptions. 9
Chapter Two - Review of texts: 11
2-1 Introduction 12
2-2 Theoretical foundations of the research. 12
2-3 review of studies conducted 12
2-3-1 review of studies conducted in Iran: 12
2-3-2 review of studies conducted in the world: 15
Chapter 3 - research method: 23
3-1 introduction 24
3-2 type of research. 25
3-3 Research community: along with entry and exit criteria. 26
3-4 Sampling method and sample size: characteristics of the examined samples (entry and exit criteria) along with sampling method and sample size 27
Determining the sample size and how to calculate it (Sample Size): 27
3-5 method of data collection and research implementation. 28
6-3 data collection tool 30
3-7 data analysis method 32
3-8 place and time of study 33
3-9 limitation of research. 33
3-10 ethical considerations. 34
3-10 definitions of terms 34
Chapter four - findings: 37
Chapter five - discussion, conclusions and suggestions: 45
Discussion section: 46
Effect of probiotics on fasting blood sugar 46
Effect of probiotics on lipid profile: 49
The effect of probiotics on insulin. 51
The role of probiotics in insulin resistance (IR) 52
The effect of probiotics on body weight and food intake. 53
Conclusion section: 56
Suggestions section: 57
Resources: 59
Appendices 67
Appendix No. 1: 67
Sample consent form 67
Appendix No. 2: 69
Sample information sheet. 69
A brief introduction in simple language with Persian corrections understandable for all subjects about the topic and purpose of the research: 69
Appendix No. 3: 71
Appendix No. 4: 72
24-hour food reminder sample. 72
Appendix No. 5: 73
Physical activity assessment questionnaire. 73
Abstract: 74
Source:
ADDIN EN.REFLIST
Al-Salami, H., G. Butt, J. P. Fawcett, I. G. Tucker, S. Golocorbin-Kon and M. Mikov (2012). "Probiotic treatment reduces blood glucose levels and increases systemic absorption of gliclazide in diabetic rats." European Journal of Drug Metabolism and Pharmacokinetics 33(2): 101-106.
Al-Salami, H., G. Butt, I. Tucker, S. Golocorbin-Kon and M. Mikov (2012). "Probiotics decreased the bioavailability of the bile acid analog, monoketocholic acid, when coadministered with gliclazide, in healthy but not diabetic rats." European Journal of Drug Metabolism and Pharmacokinetics 37(2): 99-108.
Andersson, U., C. Branning, S. Ahrne, G. Molin, J. Alenfall, G. Onning, et al. (2010). "Probiotics lower plasma glucose in the high-fat fed C57BL/6J mouse." Benef Microbes 1(2): 189-196.
Andreasen, A. S., N. Larsen, T. Pedersen-Skovsgaard, R. M. Berg, K. Moller, K. D. Svendsen, et al. (2010). "Effects of Lactobacillus acidophilus NCFM on insulin sensitivity and the systemic inflammatory response in human subjects." Br J Nutr 104(12): 1831-1838.
Andresean, V. and D. C. Baumgart (2007). "Role of probiotics in the treatment of irritable bowel syndrome: potential."Role of probiotics in the treatment of irritable bowel syndrome: potential mechanisms and current clinical evidence. international journal of probiotics and prebiotics 1: 8.
Asemi, Z., A. Khorrami-Rad, S. A. Alizadeh, H. Shakeri and A. Esmaillzadeh (2014). "Effects of synbiotic food consumption on metabolic status of diabetic patients: a double-blind randomized cross-over controlled clinical trial." Clin Nutr 33(2): 198-203.
Asemi, Z., M. Samimi, Z. Tabassi, M. Naghibi Rad, A. Rahimi Foroushani, H. Khorammian, et al. (2013). "Effect of daily consumption of probiotic yogurt on insulin resistance in pregnant women: A randomized controlled trial." European Journal of Clinical Nutrition 67(1): 71-74.
Asemi, Z., Z. Zare, H. Shakeri, S. S. Sabihi and A. Esmaillzadeh (2013). "Effect of multispecies probiotic supplements on metabolic profiles, hs-CRP, and oxidative stress in patients with type 2 diabetes." Ann Nutr Metab 63(1-2): 1-9.
Ashar, M. N. and J. B. Prajapati (2000). "Verification of hypocholesterolemic effect of fermented milk on human subjects with different cholesterol levels." Folia Microbiol (Prague) 45(3): 263-268.
Association, A. D. (2014). "Standards of Medical Care in Diabetes—2014." Diabetes Care 37(Supplement 1): S14-S80.
Azizi, F., H. Hatami and M. Janghorbani (2007). "Epidemiology and control of common diseases in Iran." 4.
Bee and Peta. (November 2008). "Probiotics, Not so friendly after all" http://www.timesonline.co.uk/tol/life_and_style/health/features/article5109777.ece." The Times (London), from http://www.timesonline.co.uk/tol/life_and_style/health/features/article5109777.ece.
Bejar, W., K. Hamden, R. Ben Salah and H. Chouayekh (2013). "Lactobacillus plantarum significantly reduces complications of alloxan-induced diabetes in rats." Besselink MG, v. S. H. (February 2008). "Probiotic prophylaxis in predicted severe pancreatitis." Lancet 371 9613: 8.
Calcinaro, F., S. Dionisi, M. Marinaro, P. Candeloro, V. Bonato, S. Marzotti, et al. (2005). "Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse." Diabetologia 48(8): 1565-1575.
Chen, P., Q. Zhang, H. Dang, X. Liu, F. Tian, ??J. Zhao, et al. (2014). "Antidiabetic effect of Lactobacillus casei CCFM0412 on mice with type 2 diabetes induced by a high-fat diet and streptozotocin." Nutrition 30(9): 1061-1068.
Chiu, C. Lu, Y. Y. Tseng, T. M. Pan (2006). "The effects of Lactobacillus-fermented milk on lipid metabolism in hamsters fed on high-cholesterol diet." Appl Microbiol Biotechnol 71(2): 238-245.
Choi, H. J., J. Yu, H. Choi, J. H. An, S. W. Kim, K. S. Park, et al. (2011). "Vitamin K2 supplementation improves insulin sensitivity via osteocalcin metabolism: a placebo-controlled trial." Diabetes Care 34(9): e147.
Daily Mail, from http://www.dailymail.co.uk/health/article-510978/So-called-friendly-bacteria-dangerous-according-new-research-taking.html
Dalla Vestra, M., M. Mussap, P. Gallina, M. Bruseghin, A. M. Cernigoi, A. Saller, et al. (2005). "Acute-phase markers of inflammation and glomerular structure in patients with type 2 diabetes." J Am Soc Nephrol 16 Suppl 1: S78-82.
Davari, S., S. A. Talaei, H. Alaei and M. Salami (2013). "Probiotics treatment improves diabetes-induced impairment of synaptic activity and cognitive function: behavioral and electrophysiological evidence for microbiome-gut-brain axis." Neuroscience 240: 287-296.
Davari, S., S. A. Talaei, M. Salami, M. R. Fazeli and H. Alaei (2013). "Effects of supplementation with probiotics on long-term potentiation impairment in diabetic rats." Journal of Isfahan Medical School 30(218): 2236-2247.
Davari, S., S. A. Talaei, M. Soltani, H. Alaei and M. Salami (2012).